Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07014605Not ApplicableNot Yet Recruiting

Smoking Cessation Program for Lao People With HIV

Role: collaborator

NCT05233228Phase 2Recruiting

Mobile Health Technology for Personalized Tobacco Cessation Support in Laos

Role: collaborator

NCT05253573Phase 2Completed

Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors in Laos

Role: collaborator

All 3 trials loaded